Kamada Pre-Announces Certain Preliminary Financial Results For Second Quarter And First Six Months Of 2017 Post author:Sam Post published:July 27, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like How Roche Fine-Tuned an Old Drug Under a New Name to Keep Making Profits August 23, 2017 Celyad Grants To Novartis AG A Non-Exclusive License For Its Allogeneic TCR-Deficient CAR-T Cells Patents May 1, 2017 2 Under-the-Radar Pharma M&A Targets for 2018 January 10, 2018
Celyad Grants To Novartis AG A Non-Exclusive License For Its Allogeneic TCR-Deficient CAR-T Cells Patents May 1, 2017